Humana Inc. (HUM)

$500.35

+8.37

(+1.7%)▲

Market is closed - opens 8 PM, 06 Dec 2023

Performance

  • $488.74
    $502.68
    $500.35
    downward going graph

    2.32%

    Downside

    Day's Volatility :2.77%

    Upside

    0.46%

    downward going graph
  • $422.53
    $549.75
    $500.35
    downward going graph

    15.55%

    Downside

    52 Weeks Volatility :23.14%

    Upside

    8.99%

    downward going graph

Returns

PeriodHumana Inc.
3 Months
7.59%
6 Months
-2.11%
1 Year
-8.42%
3 Years
23.93%

Highlights

Market Capitalization
61.0B
Book Value
$137.67
Dividend Share
3.443
Dividend Yield
0.71%
Earnings Per Share (EPS)
24.17
PE Ratio
20.49
PEG Ratio
1.06
Wall Street Target Price
585.28
Profit Margin
2.95%
Operating Margin TTM
4.82%
Return On Assets TTM
5.66%
Return On Equity TTM
18.04%
Revenue TTM
102.4B
Revenue Per Share TTM
821.03
Quarterly Revenue Growth YOY
15.9%
Gross Profit TTM
17.2B
EBITDA
5.2B
Diluted Eps TTM
24.17
Quarterly Earnings Growth YOY
-0.28
EPS Estimate Current Year
28.29
EPS Estimate Next Year
31.56
EPS Estimate Current Quarter
7.16
EPS Estimate Next Quarter
2.82

Analyst Recommendation

Buy
    72%Buy
    28%Hold
    0
    0%Sell
Based on 25 Wall street analysts offering stock ratings for Humana Inc.(by analysts ranked 0 to 5 stars)
Based on 25 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
20
21
Hold
7
7
8
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 16.97%

Current $500.35
Target $585.28

Company Financials

FY17Y/Y Change
Revenue
53.8B
↓ 1.13%
Net Income
2.4B
↑ 298.7%
Net Profit Margin
4.55%
↑ 3.42%
FY18Y/Y Change
Revenue
56.9B
↑ 5.85%
Net Income
1.7B
↓ 31.25%
Net Profit Margin
2.96%
↓ 1.59%
FY19Y/Y Change
Revenue
64.9B
↑ 14.01%
Net Income
2.7B
↑ 60.84%
Net Profit Margin
4.17%
↑ 1.21%
FY20Y/Y Change
Revenue
77.2B
↑ 18.9%
Net Income
3.4B
↑ 24.38%
Net Profit Margin
4.36%
↑ 0.19%
FY21Y/Y Change
Revenue
83.1B
↑ 7.66%
Net Income
2.9B
↓ 12.89%
Net Profit Margin
3.53%
↓ 0.83%
FY22Y/Y Change
Revenue
92.9B
↑ 11.81%
Net Income
2.8B
↓ 4.33%
Net Profit Margin
3.02%
↓ 0.51%
Q2 FY22Q/Q Change
Revenue
23.7B
↓ 1.28%
Net Income
697.0M
↓ 25.05%
Net Profit Margin
2.95%
↓ 0.93%
Q3 FY22Q/Q Change
Revenue
22.8B
↓ 3.65%
Net Income
1.2B
↑ 71.16%
Net Profit Margin
5.23%
↑ 2.28%
Q4 FY22Q/Q Change
Revenue
22.4B
↓ 1.58%
Net Income
-15.0M
↓ 101.26%
Net Profit Margin
-0.07%
↓ 5.3%
Q1 FY23Q/Q Change
Revenue
26.7B
↑ 19.18%
Net Income
1.2B
↓ 8360.0%
Net Profit Margin
4.63%
↑ 4.7%
Q2 FY23Q/Q Change
Revenue
26.7B
↑ 0.02%
Net Income
959.0M
↓ 22.6%
Net Profit Margin
3.59%
↓ 1.04%
Q3 FY23Q/Q Change
Revenue
26.4B
↓ 1.21%
Net Income
832.0M
↓ 13.24%
Net Profit Margin
3.15%
↓ 0.44%
FY17Y/Y Change
Total Assets
27.2B
↑ 7.02%
Total Liabilities
17.3B
↑ 17.84%
FY18Y/Y Change
Total Assets
25.4B
↓ 6.49%
Total Liabilities
15.3B
↓ 12.02%
FY19Y/Y Change
Total Assets
29.1B
↑ 14.41%
Total Liabilities
17.0B
↑ 11.7%
FY20Y/Y Change
Total Assets
35.0B
↑ 20.28%
Total Liabilities
21.2B
↑ 24.68%
FY21Y/Y Change
Total Assets
44.3B
↑ 26.81%
Total Liabilities
28.2B
↑ 32.95%
FY22Y/Y Change
Total Assets
43.1B
↓ 2.9%
Total Liabilities
27.7B
↓ 1.97%
Q2 FY22Q/Q Change
Total Assets
46.8B
↑ 1.11%
Total Liabilities
31.3B
↑ 1.11%
Q3 FY22Q/Q Change
Total Assets
50.8B
↑ 8.43%
Total Liabilities
34.4B
↑ 10.02%
Q4 FY22Q/Q Change
Total Assets
43.1B
↓ 15.19%
Total Liabilities
27.7B
↓ 19.63%
Q1 FY23Q/Q Change
Total Assets
54.8B
↑ 27.22%
Total Liabilities
38.1B
↑ 37.77%
Q2 FY23Q/Q Change
Total Assets
56.5B
↑ 3.07%
Total Liabilities
39.6B
↑ 3.73%
Q3 FY23Q/Q Change
Total Assets
55.9B
↓ 0.97%
Total Liabilities
38.9B
↓ 1.68%
FY17Y/Y Change
Operating Cash Flow
4.1B
↑ 109.25%
Investing Cash Flow
-2.9B
↑ 115.93%
Financing Cash Flow
-945.0M
↓ 229.1%
FY18Y/Y Change
Operating Cash Flow
2.2B
↓ 46.36%
Investing Cash Flow
-3.1B
↑ 4.96%
Financing Cash Flow
-785.0M
↓ 16.93%
FY19Y/Y Change
Operating Cash Flow
5.3B
↑ 143.17%
Investing Cash Flow
-1.3B
↓ 58.6%
Financing Cash Flow
-2.3B
↑ 192.36%
FY20Y/Y Change
Operating Cash Flow
5.6B
↑ 6.72%
Investing Cash Flow
-3.1B
↑ 139.83%
Financing Cash Flow
-2.0B
↓ 14.81%
FY21Y/Y Change
Operating Cash Flow
2.3B
↓ 59.89%
Investing Cash Flow
-6.6B
↑ 113.9%
Financing Cash Flow
3.0B
↓ 254.22%
FY22Y/Y Change
Operating Cash Flow
4.6B
↑ 102.79%
Investing Cash Flow
-1.0B
↓ 84.66%
Financing Cash Flow
-1.9B
↓ 163.48%
Q2 FY22Q/Q Change
Operating Cash Flow
959.0M
↑ 217.55%
Investing Cash Flow
-1.0B
↑ 57.72%
Financing Cash Flow
419.0M
↓ 76.93%
Q3 FY22Q/Q Change
Operating Cash Flow
8.5B
↑ 781.44%
Investing Cash Flow
1.7B
↓ 263.99%
Financing Cash Flow
-1.8B
↓ 527.45%
Q4 FY22Q/Q Change
Operating Cash Flow
-5.1B
↓ 160.65%
Investing Cash Flow
-1.0B
↓ 160.02%
Financing Cash Flow
-2.4B
↑ 31.66%
Q1 FY23Q/Q Change
Operating Cash Flow
6.7B
↓ 230.43%
Investing Cash Flow
-1.3B
↑ 28.43%
Financing Cash Flow
3.3B
↓ 239.06%
Q2 FY23Q/Q Change
Operating Cash Flow
3.2B
↓ 52.5%
Investing Cash Flow
-733.0M
↓ 43.27%
Financing Cash Flow
36.0M
↓ 98.9%
Q3 FY23Q/Q Change
Operating Cash Flow
1.3B
↓ 60.58%
Investing Cash Flow
-2.6B
↑ 256.07%
Financing Cash Flow
-1.7B
↓ 4913.89%

Technicals Summary

Sell

Neutral

Buy

Humana Inc. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Humana Inc.
Humana Inc.
2.68%
-2.11%
-8.42%
23.93%
58.2%
The Cigna Corp
The Cigna Corp
-15.99%
-2.06%
-21.8%
17.93%
20.29%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
3.15%
12.86%
2.03%
58.18%
98.76%
Cvs Health Corporation
Cvs Health Corporation
-0.08%
0.72%
-29.82%
-3.54%
-7.25%
Elevance Health, Inc
Elevance Health, Inc
6.06%
3.76%
-8.77%
51.0%
67.72%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Humana Inc.
Humana Inc.
20.49
20.49
1.06
28.29
0.18
0.06
0.01
137.67
The Cigna Corp
The Cigna Corp
15.06
15.06
0.89
24.83
0.12
0.04
0.02
155.78
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
23.78
23.78
1.5
24.96
0.25
0.08
0.01
91.35
Cvs Health Corporation
Cvs Health Corporation
10.49
10.49
0.31
8.58
0.12
0.04
0.04
57.76
Elevance Health, Inc
Elevance Health, Inc
18.68
18.68
1.01
33.06
0.17
0.05
0.01
163.57
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Humana Inc.
Humana Inc.
Buy
$61.0B
58.2%
20.49
2.95%
The Cigna Corp
The Cigna Corp
Buy
$78.1B
20.29%
15.06
2.79%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$506.8B
98.76%
23.78
6.02%
Cvs Health Corporation
Cvs Health Corporation
Buy
$88.1B
-7.25%
10.49
2.44%
Elevance Health, Inc
Elevance Health, Inc
Buy
$112.8B
67.72%
18.68
3.63%

Institutional Holdings

  • Vanguard Group Inc

    9.09%

  • BlackRock Inc

    8.68%

  • T. Rowe Price Associates, Inc.

    5.75%

  • Wellington Management Company LLP

    5.47%

  • State Street Corporation

    4.57%

  • FMR Inc

    4.05%

Corporate Announcements

  • Humana Inc. Dividends March,2023

    In the quarter ending March,2023. Humana Inc. has declared dividend of $0.89

    Read More

Company Information

at humana, our cultural foundation is aligned to helping members achieve their best health by delivering personalized, simplified, whole-person healthcare experiences. recognizing healthcare needs continue to evolve for each person, for each family and for each community, humana continuously creates innovative solutions and resources that help people live their healthiest lives on their terms –when and where they need it. our employees are at the heart of making this happen and that’s why we are dedicated to building an organization of dynamic talent whose experience and passion center on putting the customer first.

Organization
Humana Inc.
Employees
67100
CEO
Mr. Bruce Dale Broussard
Industry
Health Services

Discover More

FAQs